BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2635732)

  • 1. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M
    J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
    Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
    Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M; Tashiro H; Akazawa F
    J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
    Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
    Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
    Konishi T
    Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new simple test for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
    World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic carboxypeptidase hydrolysis of bile acid-amino conjugates: selective resistance of glycine and taurine amidates.
    Huijghebaert SM; Hofmann AF
    Gastroenterology; 1986 Feb; 90(2):306-15. PubMed ID: 2867000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly synthesized compound, PABA-ursodeoxycholic acid, for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Matsuno K; Tamura H; Furuyashiki S; Harada M
    Hiroshima J Med Sci; 1987 Dec; 36(4):377-81. PubMed ID: 3502343
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine.
    Sterchi EE; Green JR; Lentze MJ
    Clin Sci (Lond); 1982 May; 62(5):557-60. PubMed ID: 7042181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpancreatic hydrolysis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA peptide) in the rat small intestine.
    Sterchi EE; Green JR; Lentze MJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):539-47. PubMed ID: 6352892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
    Konishi T; Takahashi M; Ohta S
    Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and metabolic characteristics of p-aminobenzoic acid and its isomer, m-aminobenzoic acid, from the rat small intestine.
    Yamamoto A; Sakane T; Shibukawa M; Hashida M; Sezaki H
    J Pharm Sci; 1991 Nov; 80(11):1067-71. PubMed ID: 1815058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The ursodeoxycholic acid-p-aminobenzoic acid test in the diagnosis of small bowel bacterial overgrowth syndrome].
    Kiss Z; Wölfling J; Csáti S; Nagy F; Lonovics J; Schneider G
    Orv Hetil; 1997 May; 138(20):1255-8. PubMed ID: 9244859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of the BT-PABA test for the diagnosis of exocrine pancreatic insufficiency in the dog.
    Batt RM; Mann LC
    Vet Rec; 1981 Apr; 108(14):303-7. PubMed ID: 6972120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides.
    Sterchi EE; Naim HY; Lentze MJ; Hauri HP; Fransen JA
    Arch Biochem Biophys; 1988 Aug; 265(1):105-18. PubMed ID: 3261961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the absorption of the pancreatic function test peptide, N-benzoyl-L-tyrosyl-p-aminobenzoic acid, and related compounds by isolated rat small intestine.
    Gardner ML; Mitchell CJ
    Q J Exp Physiol; 1981 Jan; 66(1):17-24. PubMed ID: 6973773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations of the in-vitro metabolism of three opioid tetrapeptides by pancreatic and intestinal enzymes.
    Krondahl E; Von Euler-Chelpin H; Orzechowski A; Ekström G; Lennernäs H
    J Pharm Pharmacol; 2000 Jul; 52(7):785-95. PubMed ID: 10933129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal absorption of ursodeoxycholic, glycoursodeoxycholic and tauroursodeoxycholic acids in rats.
    Ota M; Minami Y; Hoshita T
    J Pharmacobiodyn; 1985 Feb; 8(2):114-8. PubMed ID: 4009402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis and metabolism of N-benzoyl-L-tyrosyl-p-aminobenzoic acid in normal and pancreatic duct-ligated animals.
    Yamato C; Kinoshita K
    J Pharmacol Exp Ther; 1978 Aug; 206(2):468-74. PubMed ID: 682127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
    Batta AK; Tint GS; Xu G; Shefer S; Salen G
    J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.